openPR Logo
Press release

LATAM Pain Management Drug Market Report 2020-2027

02-18-2021 11:11 AM CET | Health & Medicine

Press release from: Report Ocean

According to a new report published by Report Ocean, titled, “LATAM Pain management drug market by drug class and indication: regional opportunity analysis and industry forecast, 2019–2027.

GET SAMPLE PAGES @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1316

The LATAM pain management drugs market was valued at $2,683.82 million in 2019, and is projected to reach $3,383.20 million by 2027, registering a CAGR of 3.5% from 2020 to 2027.

Pain is a complex medical condition, which not only affects physical but also mental well-being of an individual. It is caused due to trauma or tissue damage, and its intensity varies from person to person. On the basis of cause of pain, the treatment provided can be simple or complex. Pain can be managed using a variety of pharmacological and non-pharmacological therapies.

Availability of sophisticated treatment options and advancements in technologies have increased life expectancy rates in Latin America, which has resulted in increase of geriatric population. In addition, elderly people are more prone to suffer from pain, owing to various reasons such as rise in incidences and prevalence of chronic diseases such as heart diseases, stroke, type II diabetes, and cancer, which drives the LATAM pain management drugs market growth. According to the WHO, geriatric population was approximately 56.4 million in 2019 in Latin America. Moreover, increase in R&D investments and rise in outsourcing of pharmaceuticals are expected to fuel the market growth in Latin America. However, availability of alternative therapies and patent expiration of prescription drugs for treatment of pain hamper growth of the LATAM pain management drugs market.

The opioids segment was the largest contributor to the LATAM pain management drugs market growth in 2019, owing to high efficiency of opioids to relieve pain in major chronic conditions. The anti-migraine agents segment is anticipated to possess highest growth rate during the forecast period.

Neuropathic pain and chronic back pain were among the largest revenue contributors in 2019, owing to increase in number of surgeries in Latin America and rise in prevalence of chronic diseases that lead to back pain. Furthermore, the cancer pain segment is expected to grow at the highest rate throughout the forecast period, owing to rise in prevalence of cancer in the region.

Brazil is expected to generate highest revenue during the forecast period. However, Argentina is projected to grow at the highest CAGR during the forecast period, owing to increase in government initiatives to improve healthcare infrastructure and improved regulatory framework.

As per the industry experts, long term effect of COVID-19 outbreak is expected to be witnessed over the coming years. This pandemic has disrupted growth in many economies across various domains. The COVID-19 outbreak will impact the pain management drugs market in the initial phase of the forecast period. The COVID-19 pandemic has stressed healthcare systems worldwide, so that many clinics, pain services are no longer open for public services because of safety. Moreover, throughout the latter half of the forecast period, the demand for pain management drugs is expected to rise. Owing to the factors such as telemedicine, physicians are able to provide guidance to patients for physical exercises at-home for pain relief. This is anticipated to increase the market growth in near future.

The report provides some of the key players operating in the LATAM pain management drugs market include Abbott Laboratories Novartis AG, Eli Lilly & Company, Abbott Laboratories, Pfizer, Inc., Mylan NV., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc. The other prominent players in the value chain include Allergen Inc., Bayer AG, Bristol-Myers Squibb, Valeant Pharmaceuticals International Inc., Boehringer Ingelheim, Sorrento Therapeutics, WEX Pharmaceuticals, and Zynerba Pharmaceuticals.

Key Findings Of The Study

By drug class, the opioids segment generated $683 million of the LATAM pain management drug market in 2019.
By indication, the cancer pain segment is anticipated to grow with the highest CAGR throughout the forecast period.
By country, Brazil is accounted for the largest market in LATAM during the forecast period.

READ FULL REPORT @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1316

Get in Touch with Us:
Report Ocean
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.reportocean.com/

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release LATAM Pain Management Drug Market Report 2020-2027 here

News-ID: 2244608 • Views: 249

More Releases from Report Ocean

Low-Speed Electric Vehicle (LSEV) Market is Going to Boom with Fulu Vehicle, YOG …
The ' Low-Speed Electric Vehicle (LSEV) market' research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market overview, Low-Speed Electric Vehicle (LSEV) market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Low-Speed Electric
Automotive HD Maps Market Is Likely to Experience a Tremendous Growth in Near Fu …
The ' Automotive HD Maps market' research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market overview, Automotive HD Maps market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Automotive HD Maps market
Automotive Infotainment Technologies Market Is Likely to Experience a Tremendous …
The ' Automotive Infotainment Technologies market' research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market overview, Automotive Infotainment Technologies market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Automotive Infotainment Technologies market
Automotive Chemicals Market To See Stunning Growth | British Petroleum, Fuchs Lu …
The ' Automotive Chemicals market' research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market overview, Automotive Chemicals market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Automotive Chemicals market size forecast, market

All 5 Releases


More Releases for LATAM

LATAM Hypoactive Sexual Desire Disorder Treatment Market Report 2020-2027
According to a new report published by Report Ocean, titled, "LATAM hypoactive sexual desire disorder treatment market by Treatment Type and Sales Channel: Regional Opportunity Analysis and Industry Forecast, 2019–2027," the LATAM hypoactive sexual desire disorder treatment market size was valued at $967million in 2019, and is expected to reach $1,275 million by 2027, registering a CAGR of 6.1% from 2019 to 2027. GET SAMPLE PAGES @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1315 Hypoactive sexual desire
Pipeline Analysis: LATAM Adalimumab Market
The Latin America (LATAM) adalimumab market features the dominance of few companies operating amid a lackluster market, a limited set of growth opportunities, and the looming threat of biosimilars, observes Transparency Market Research in a report. The drug being a biologic, carries a high price tag, making it difficult for the largely cost-conscious consumers in the region to procure it. The presence of several biosimilars and the projected introduction of
12-26-2017 | Health & Medicine
TMR
LATAM Adalimumab Market Overview, Trends and Forecast 2015
The Latin America (LATAM) adalimumab market features the dominance of few companies operating amid a lackluster market, a limited set of growth opportunities, and the looming threat of biosimilars, observes Transparency Market Research in a report. The drug being a biologic, carries a high price tag, making it difficult for the largely cost-conscious consumers in the region to procure it. The presence of several biosimilars and the projected introduction of several new
10-11-2017 | Health & Medicine
TMR
LATAM Adalimumab Market – Global Industry Analysis 2015
The Latin America (LATAM) adalimumab market features the dominance of few companies operating amid a lackluster market, a limited set of growth opportunities, and the looming threat of biosimilars, observes Transparency Market Research in a report. The drug being a biologic, carries a high price tag, making it difficult for the largely cost-conscious consumers in the region to procure it. The presence of several biosimilars and the projected introduction of several new
LATAM Cord Blood Banking Services Market: Regional & Competitive Analysis
A per the TMR’s report, the Latin America market for cord blood banking services was worth US$196.9 mn in 2014. Researchers project the market to proliferate at a CAGR of 9.40% over the period from 2015 to 2023 and attain a value of US$445.4 mn by the end of the forecast period. View Full Report: http://www.transparencymarketresearch.com/latam-cord-blood-banking-services-market.html Public Cord Blood Banking Services to Report Dominance Currently, cord blood banking services are being
Mobile Broadband LatAm looks at expected market explosion
The largest Latin American mobile network operators and global high-tech giants are meeting in Rio de Janeiro in April to strategize on how best to take advantage of the enormous explosion that is expected in the entire Latin American mobile broadband market. Mobile Broadband LatAm is the first event to bring together the entire industry ecosystem and takes place from 7-9 June. MTN, the South African mobile operator